Deanna Garcia, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 750 W Fm 544, Wylie, TX 75098 Phone: 817-925-0901 |
Mrs. Suzanne Thompson Martin, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 501 Woodbridge Pkwy, Wylie, TX 75098 Phone: 972-442-2300 |
Nora R Fallon, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 601 Sanden Blvd, Wylie, TX 75098 Phone: 615-778-4066 Fax: 615-778-9114 |
Jennifer Lynn Pomales, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 704 Riverhead Dr, Wylie, TX 75098 Phone: 214-641-5787 |
Mrs. Quynh N. Vu, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 750 W Fm 544, Wylie, TX 75098 Phone: 866-389-2727 Fax: 401-216-3854 |
News Archive
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a regulatory update on Zalviso (sufentanil sublingual tablet system) intended for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
Monitoring the rehabilitation of patients with neurological damage caused by a stroke, has encouraged Mexican scientists to work in the design and manufacture of a functional infrared spectroscopy (fNIRS -FD ) instrument capable of identifying the affected areas of the brain and the sites that were activated while analyzing the oxygen content in blood flow during therapy.
Catalyst Pharmaceutical Partners, Inc. today reported that a team of neuroscientists at The Feinstein Institute for Medical Research at North Shore-Long Island Jewish Health System (LIJ) has received a $1.2 million grant from the U.S. Department of Defense (DOD) to conduct an animal study of the use of vigabatrin in combination with opiates to effectively manage pain while reducing the potential for opiate addiction.
› Verified 6 days ago